ATE232389T1 - Inhibierung von c. difficile-infektionen mit unverdaulichen oligosacchariden - Google Patents

Inhibierung von c. difficile-infektionen mit unverdaulichen oligosacchariden

Info

Publication number: ATE232389T1
Authority: AT; Austria
Prior art keywords: difficile; indigestible oligosaccharides; diarrhea; microflora; inhibit
Prior art date: 1995-04-05

Application number

AT96912568T

Other languages

English (en)

Inventor

Keith Allen Garleb

Brian Warren Wolf

Jonathan Allan Meulbroek

Keith Brian Wheeler

Shelia Martinson Campbell

Joseph Edward Walton

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-04-05

Filing date

1996-04-04

Publication date

2003-02-15

1995-04-05 Priority claimed from US08/417,411 external-priority patent/US5733579A/en

1995-04-05 Priority claimed from US08/417,413 external-priority patent/US5688777A/en

1996-04-04 Application filed by Abbott Lab filed Critical Abbott Lab

2003-02-15 Application granted granted Critical

2003-02-15 Publication of ATE232389T1 publication Critical patent/ATE232389T1/de

Links

241000193163 Clostridioides difficile Species 0.000 title abstract 7
229920001542 oligosaccharide Polymers 0.000 title abstract 3
150000002482 oligosaccharides Chemical class 0.000 title abstract 3
208000015181 infectious disease Diseases 0.000 title abstract 2
230000005764 inhibitory process Effects 0.000 title 1
206010012735 Diarrhoea Diseases 0.000 abstract 3
244000005706 microflora Species 0.000 abstract 3
206010009657 Clostridium difficile colitis Diseases 0.000 abstract 1
208000012868 Overgrowth Diseases 0.000 abstract 1
208000003100 Pseudomembranous Enterocolitis Diseases 0.000 abstract 1
206010037128 Pseudomembranous colitis Diseases 0.000 abstract 1
239000003242 anti bacterial agent Substances 0.000 abstract 1
229940088710 antibiotic agent Drugs 0.000 abstract 1
230000003115 biocidal effect Effects 0.000 abstract 1
206010009887 colitis Diseases 0.000 abstract 1
230000018044 dehydration Effects 0.000 abstract 1
238000006297 dehydration reaction Methods 0.000 abstract 1
239000003792 electrolyte Substances 0.000 abstract 1
230000003090 exacerbative effect Effects 0.000 abstract 1
239000012530 fluid Substances 0.000 abstract 1
238000010606 normalization Methods 0.000 abstract 1
239000000310 rehydration solution Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hematology (AREA)
Saccharide Compounds (AREA)
Medicinal Preparation (AREA)

AT96912568T 1995-04-05 1996-04-04 Inhibierung von c. difficile-infektionen mit unverdaulichen oligosacchariden ATE232389T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/417,411 US5733579A (en)	1995-04-05	1995-04-05	Oral rehydration solution containing indigestible oligosaccharides
US08/417,413 US5688777A (en)	1995-04-05	1995-04-05	Inhibition of C. difficile infections by indigestible oligosaccharides
PCT/US1996/004665 WO1996031219A1 (en)	1995-04-05	1996-04-04	Inhibition of c. difficile infections by indigestible oligosaccharides

Publications (1)

Publication Number	Publication Date
ATE232389T1 true ATE232389T1 (de)	2003-02-15

Family

ID=27023728

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96912568T ATE232389T1 (de)	1995-04-05	1996-04-04	Inhibierung von c. difficile-infektionen mit unverdaulichen oligosacchariden

Country Status (13)

Country	Link
EP (1)	EP0820292B1 (de)
JP (1)	JPH11503168A (de)
AT (1)	ATE232389T1 (de)
AU (1)	AU704004B2 (de)
CA (1)	CA2217157C (de)
DE (1)	DE69626200T2 (de)
DK (1)	DK0820292T3 (de)
ES (1)	ES2194988T3 (de)
MX (1)	MX9707631A (de)
NO (1)	NO313685B1 (de)
NZ (1)	NZ306712A (de)
PT (1)	PT820292E (de)
WO (1)	WO1996031219A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60031385D1 (de) *	2000-06-28	2006-11-30	B S D Bio Science Dev Snc Di O	Pharmazeutische Zusammensetzungen von Antibiotika und Fruktan-Gemische
EP1243273A1 (de) †	2001-03-22	2002-09-25	Societe Des Produits Nestle S.A.	Zubereitung enthaltend einen praebiotischen Stoff für die Behandlung von Entzündungen und abnormale Aktivierung von nicht-spezifischen immunologischen Parametern
JP2008514651A (ja) *	2004-09-30	2008-05-08	ユニバーシティー・テクノロジーズ・インターナショナル・インコーポレイテッド	上皮増殖因子（ｅｇｆ）を含んで成る再水和組成物
US20100063002A1 (en) *	2007-03-13	2010-03-11	Bernd Stahl	Method of improving skills with a composition comprising non-digestible saccharide
US20190070204A1 (en) *	2016-03-14	2019-03-07	B Food Science Co., Ltd.	Proliferative agent for faecalibacterium
JP7688866B2 (ja) *	2020-07-14	2025-06-05	物産フードサイエンス株式会社	筋肉量率を増加させる剤および方法、ならびに体脂肪率を減少させる剤および方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4902674A (en) *	1987-10-13	1990-02-20	Coors Biotech, Inc.	Method for inhibiting the growth of salmonella
NZ232346A (en) *	1989-02-07	1992-03-26	Duphar Int Res	Effervescent oral rehydration solution comprising saccharides, amino acids and bicarbonate salts
US5397786A (en) *	1993-01-08	1995-03-14	Simone; Charles B.	Rehydration drink

1996
- 1996-04-04 AT AT96912568T patent/ATE232389T1/de not_active IP Right Cessation
- 1996-04-04 MX MX9707631A patent/MX9707631A/es not_active IP Right Cessation
- 1996-04-04 EP EP96912568A patent/EP0820292B1/de not_active Expired - Lifetime
- 1996-04-04 JP JP8530480A patent/JPH11503168A/ja not_active Ceased
- 1996-04-04 AU AU55342/96A patent/AU704004B2/en not_active Ceased
- 1996-04-04 ES ES96912568T patent/ES2194988T3/es not_active Expired - Lifetime
- 1996-04-04 WO PCT/US1996/004665 patent/WO1996031219A1/en not_active Ceased
- 1996-04-04 DE DE69626200T patent/DE69626200T2/de not_active Expired - Lifetime
- 1996-04-04 CA CA002217157A patent/CA2217157C/en not_active Expired - Fee Related
- 1996-04-04 PT PT96912568T patent/PT820292E/pt unknown
- 1996-04-04 DK DK96912568T patent/DK0820292T3/da active
- 1996-04-04 NZ NZ306712A patent/NZ306712A/en unknown
1997
- 1997-09-29 NO NO19974490A patent/NO313685B1/no unknown

Also Published As

Publication number	Publication date
CA2217157C (en)	2002-07-30
MX9707631A (es)	1998-04-30
DE69626200T2 (de)	2003-12-18
JPH11503168A (ja)	1999-03-23
HK1008492A1 (en)	1999-05-14
EP0820292B1 (de)	2003-02-12
EP0820292A1 (de)	1998-01-28
NO974490D0 (no)	1997-09-29
NO313685B1 (no)	2002-11-18
WO1996031219A1 (en)	1996-10-10
CA2217157A1 (en)	1996-10-10
AU5534296A (en)	1996-10-23
PT820292E (pt)	2003-06-30
DK0820292T3 (da)	2003-05-19
ES2194988T3 (es)	2003-12-01
DE69626200D1 (de)	2003-03-20
NO974490L (no)	1997-09-29
AU704004B2 (en)	1999-04-01
NZ306712A (en)	1999-10-28

Legal Events

Date

Code

Title

Description

2003-09-15

UEP

Publication of translation of european patent specification

Ref document number: 0820292

Country of ref document: EP

2007-01-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
US3940478A (en)	1976-02-24	Proteolytic enzymes as adjuncts to antibiotic prophylaxis of contaminated wounds
ES2091290T3 (es)	1996-11-01	Tratamiento para la diarrea por clostridium difficile y colitis pseudomembranosa.
GEP20012415B (en)	2001-04-25	THF-Containing Sulfonamide Inhibitors of Aspartyl Protease
DE69628556D1 (de)	2003-07-10	Tricyclische verbindungen als inhibitoren von farnesyl protein transferase
NO950651L (no)	1995-08-23	Antitranspirasjonsdeodorantpreparat
ES2083977T3 (es)	1996-05-01	Composiciones biocidas.
TR199700660T1 (xx)	1998-01-21	Yeni farnezil transferaz �nleyiciler.
AU5669198A (en)	1998-07-17	Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
EP1210941A3 (de)	2002-07-31	Pharmazeutische Zusammensetzungen enthaltend Ritonavir (ABT-538) in Kombination mit Indinavir (MK-639) und deren Verwendung zur Behandlung von AIDS
ATE232389T1 (de)	2003-02-15	Inhibierung von c. difficile-infektionen mit unverdaulichen oligosacchariden
EP0734387A4 (de)	1997-03-05	Hiv-proteaseinhibitoren
ES2042868T3 (es)	1993-12-16	Un metodo de producir galidermina.
MX9708611A (es)	1998-02-28	Compuestos de dialquiltiacumicina.
ES479636A1 (es)	1980-01-16	Procedimiento para la obtencion de un antibiotico de efecto sinergistico.
PT666755E (pt)	2003-09-30	Inibicao da infeccao pelo vih
DE3260277D1 (en)	1984-08-02	Peptide antibiotic, component b, process for its preparation and its use in medicines
NO944246D0 (no)	1994-11-07	Halogenerte 4'-metoksyacetofenoner som mikrobicider og preserveringsmidler
ATE36712T1 (de)	1988-09-15	Nargenicin c1.
GEP20033144B (en)	2003-12-25	Hygromycin A Derivatives as Antibacterial Agents
AU7099481A (en)	1981-12-03	Anthelmintic hydroimidazo(i,1-b)-thiazoles
ES546915A0 (es)	1987-03-01	Procedimiento para preparar nuevos antibioticos policiclicos por fermentacion de una cepa de actinomadura melliaura.
ES2093656T3 (es)	1997-01-01	Preparaciones combinadas farmaceuticas que contienen cefotaxima y derivados de la xantina y su uso.
BG102014A (en)	1998-11-30	Carbapenem esters